Home › Stocks › GENB

Generate Biomedicines, Inc. (GENB): insider buying, hedge funds & Congress trades

Generate Biomedicines, Inc. (GENB): 6 insider purchases in the last two years.

Insider buying

FiledInsiderSharesPriceValueType
Mar 6, 2026Nally Michael
Director, Officer
20,000$12.00$240.0Kno history
Mar 2, 2026Flagship Pioneering Fund VI, L.P.
TenPercentOwner
4,687,500$16.00$75.0Mno history
Mar 2, 2026Mendillo Jane L
Director
1,500$16.00$24.0Kno history
Mar 2, 2026Nutritional Health LTP Fund General Partner LLC
TenPercentOwner
4,687,500$16.00$75.0Mno history
Mar 2, 2026Silvers Jason
Officer
2,000$16.00$32.0Kno history
Mar 2, 2026Grous Beth
Officer
300$16.00$4.8Kno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for GENB

Free account. Know when insiders, famous funds or Congress trade it.

Start free